4.8
60 reviews
10K+
Downloads
Content rating
Everyone
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image

About this app

Make well-informed decisions on anti thrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for anti thrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com
Updated on
Jan 29, 2019

Data safety

Developers can show information here about how their app collects and uses your data. Learn more about data safety
No information available
4.8
60 reviews
Jeff Bara
September 4, 2021
Nice. Use all the time with patients.
Did you find this helpful?
A Google user
August 31, 2016
Very useful app
10 people found this review helpful
Did you find this helpful?
A Google user
May 25, 2019
Great application
4 people found this review helpful
Did you find this helpful?

What's new

This version includes the following:
1)  2019 AFib Guideline Update content
2)  Design updates